<DOC>
	<DOCNO>NCT01056887</DOCNO>
	<brief_summary>The differential diagnosis patient polyuria/ polydipsia often complex , important therapeutic strategy . Challenging particular clinical differentiation patient partial Diabetes insipidus centralis patient primary polydipsia underlying disease , group associate similar urinary osmolalities . The determination plasma arginine vasopressin unusual context , since measurement AVP reliably . C-terminal ProVasopressin ( copeptin ) secrete stoichiometrically AVP neurohypophysis , long half life circulation , thus easy measure . Therefore , investigator analyze study diagnostic utility plasma copeptin differential diagnosis polyuria polydipsia .</brief_summary>
	<brief_title>Copeptin Differentiation Polyuria Polydipsia</brief_title>
	<detailed_description />
	<mesh_term>Polyuria</mesh_term>
	<mesh_term>Polydipsia</mesh_term>
	<criteria>Patients polydipsia/ polyuria , indication perform deprivation test &gt; 18 year dDAVP last 14d pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>diabetes insipidus</keyword>
	<keyword>primary polydipsia</keyword>
	<keyword>copeptin</keyword>
	<keyword>Utility plasma copeptin differential diagnosis polyuria/ polydipsia perform traditional deprivation test</keyword>
</DOC>